On Monday, Seventy Seven Energy Inc (NYSE:SSE)’s shares inclined 6.67% to $3.20.
Aveda Transportation and Energy Services Inc. a leading provider of oilfield hauling services and equipment rentals to the energy industry, recently declared that, through its operating partner in the US, it has accomplished the acquisition of Hodges Trucking Company, L.L.C. (“Hodges”), from an associate of Seventy Seven Energy Inc. (SSE). The purchase price was US$42.0 million. US$15.0 million of the purchase price is financed through the Company’s existing senior credit facility and US$27.0 million is financed by a seller take-back note (the “Note”). The Note is a 5 year term debt note with no requirement for principal amortization. The Note bears interest at 9% per annum which interest shall be paid quarterly. The Note is secured by a 2nd lien on the Company’s fixed assets and accounts receivable. The Company anticipates to provide further details and an operation update later this week.
Seventy Seven Energy Inc. provides oilfield services in the United States. The company operates in four segments: Drilling, Hydraulic Fracturing, Oilfield Rentals, and Oilfield Trucking. The Drilling segment offers land drilling and drilling-related services, counting directional drilling for the oil and natural gas exploration and development activities. The Hydraulic Fracturing segment provides hydraulic fracturing and other well stimulation services.
CTI BioPharma Corp (NASDAQ:CTIC)’s shares gained 1.69% to $1.80.
CTI BioPharma Corp. (CTIC) declared findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR). These final results were presented by Dr. Giuseppe Visani, Director of Hematology and Stem Cell Transplant Center at AORMN, Pesaro, Italy in a poster session (abstract #P564) during the 20th Congress of the European Hematology Association (EHA), June 11-14, 2015 in Vienna, Austria.
AML is the most common acute leukemia affecting adults, and its incidence enhances with age. AML may develop from the progression of other diseases, such as MDS, which is a blood cancer that also affects the bone marrow and leads to a decrease in circulating red blood cells. Tosedostat is a potential first-in-class selective inhibitor of aminopeptidases, which are required by tumor cells to provide amino acids necessary for growth and tumor cell survival.
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also developing Pacritinib, an oral multikinase inhibitor with activity against Janus Kinase 2 and FMS-like tyrosine kinase, which is in Phase III clinical trials for the treatment of myelofibrosis. In addition, it is developing Tosedostat, an oral once-daily aminopeptidase inhibitor that is in Phase II/III clinical trials for the treatment of acute myeloid leukemia; and Opaxio, a chemotherapeutic agent, which is in Phase III clinical trials for the treatment of various solid tumors, counting non-small cell lung, ovarian, breast, and prostate cancers.
At the end of Monday’s trade, Enbridge Inc (USA) (NYSE:ENB)‘s shares surged 1.43% to $43.15.
Enbridge Pipelines Inc. (EPI) declared that it has accomplished its transfer of EPI’s ownership interest in Enbridge Energy Company, Inc., a wholly-owned U.S. partner of EPI, to a wholly-owned partner of Enbridge Inc. (“U.S. Reorganization”).
The U.S. Reorganization was part of a formerly planned structural reorganization, which commenced in 2011, and a pre-closing transaction for the transfer of Enbridge’s Canadian Liquids Pipelines Business and Renewable Energy Assets to the Enbridge Income Fund as formerly declared on June 19, 2015.
Enbridge Inc. operates as an energy transportation and distribution company in the United States and Canada. Its Liquids Pipelines segment operates common carrier and contract crude oil, natural gas liquids (NGL), and refined products pipelines and terminals. The company’s Gas Distribution segment operates as a natural gas utility that serves residential, commercial, and industrial customers in Central and Eastern Ontario, and Northern New York State, in addition to in Quebec and New Brunswick. Its Gas Pipelines, Processing and Energy Services segment has interests in natural gas pipelines, counting the Vector Pipeline and transmission and gathering pipelines in the Gulf of Mexico, in addition to holds an interest in Aux Sable, a natural gas fractionation and extraction facility. This segment is also involved in the renewable energy projects, such as wind, solar, and geothermal projects with a generating capacity of about 2,200 MW.
Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH), ended its Monday’s trading session with 0.59% gain, and closed at $61.42.
Norwegian Cruise Line Holdings Ltd. (NCLH) together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings”, “Norwegian” or the “Company”, stated financial results for the quarter ended June 30, 2015 and offered guidance for the third quarter and full year 2015.
Second Quarter 2015 Highlights
- Improvement in Adjusted EPS of 29.3% to $0.75 on Adjusted Net Income of $171.6 million.
- Enhance in Adjusted Net Yield on a Combined Company basis of 1.5%, or 3.2% on a Constant Currency basis, driven by pricing improvement in the quarter. Enhance of 18.2% on an as stated basis.
- Continued synergy identification efforts from the integration of Norwegian and Prestige lead to synergies of $75 million in 2015 and $125 million in 2016 preceding to reinvestment.
Norwegian Cruise Line Holdings Ltd., a cruise line operator, through its auxiliaries, provides cruise experiences for travelers with various itineraries. It offers cruises ranging from 1 day to 180 days. The company’s distribution channel comprises independent travel agents, wholesalers, and tour operators. It operates 21 ships under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands with about 40,000 lower berths visiting about 430 destinations worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
